Thursday, February 14, 2008
5:00 p.m. EST
WAKEFIELD, MA, Feb. 13 /CNW/ - NUCRYST Pharmaceuticals Corp. will hold a
webcast at 5:00 p.m. EST on Thursday, February 14, 2008 regarding the
company's 2007 fourth quarter results.
In addition to standard disclosure over wire services, a news release and
financial statements will be posted on the NUCRYST web site. To listen to the
call live on the Internet, please go to www.nucryst.com.
Thomas E. Gardner, Chairman, President, & CEO and Eliot M. Lurier, Vice
President, Finance & Administration, and CFO will participate on the call.
An audio file of the call will be archived and posted on the NUCRYST web
NUCRYST Pharmaceuticals (NASDAQ: NCST; TSX: NCS) develops, manufactures
and commercializes medical products that fight infection and inflammation
using its patented atomically disordered nanocrystalline silver technology.
Smith & Nephew plc sell a range of advanced wound care products under their
Acticoat(TM) trade mark: Acticoat(TM) products incorporate NUCRYST's
SILCRYST(TM) coatings and are sold in over 30 countries. NUCRYST is also
developing pharmaceutical products to address medical conditions that are
characterized by both infection and inflammation. The company has developed
its proprietary nanocrystalline silver in a powder form, referred to as NPI
32101 for use in medical devices and as an active pharmaceutical ingredient.
For further information:
For further information: Catherine Cloft, (781) 224-1444,